Search PubMedSearch

PubMed · 41877443

BnaPAP2.C2 plays a novel inhibitory role in anthocyanin accumulation compared to its paralogs in rapeseed (Brassica napus L.).

Abstract

Tissue-specific anthocyanin pigmentation is observed in rapeseed (Brassica napus L. AACC, 2n = 38) as well as in its ancestral diploids Brassica rapa (AA, 2n = 20) and Brassica oleracea (CC, 2n = 18). We previously identified the MYB genes BnaPAP2.A7b and BnaPAP2.C6a as key regulators of anthocyanin biosynthesis. Here we uncover an antagonistic regulatory mechanism in leaves involving their paralog BnaPAP2.C2. Unlike the pigmentation-associated genes, BnaPAP2.C2 is constitutively expressed in both green and purple leaves, regardless of anthocyanin levels. Its promoter contains two enhancers (463 and 486 bp) that synergistically regulate transcription. Competitive binding studies reveal that BnaPAP2.C2, although lacking activation capacity, sequesters BnaTT8 and outcompetes BnaPAP2.A7b, thereby suppressing anthocyanin biosynthesis. Under environmental stress, elevated expression of BnaPAP2.A7b promotes anthocyanin biosynthesis, whereas BnaPAP2.C2 is downregulated. This paralog-specific molecular antagonism provides new insight into the evolution of MYB-bHLH interaction specificity. Together, these findings uncover a novel inhibitory mechanism within the anthocyanin regulatory hierarchy of polyploid rapeseed, highlighting competitive binding as an evolutionary innovation driving functional diversification of duplicated MYB regulators.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Linshan Xu, Xiaodi Chen, Jizhao Yang, Yuanjun Teng, Jie Qiu, Graham J King, Jing Wang, Guangsheng Zhou, Xianhong Ge. 2026. BnaPAP2.C2 plays a novel inhibitory role in anthocyanin accumulation compared to its paralogs in rapeseed (Brassica napus L.).. https://doi.org/10.1111/tpj.70801

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A stable transformation platform in pomegranate uncovers PgMYB10 as a key regulator of anthocyanin biosynthesis.

An efficient genetic transformation platform enables functional validation of PgMYB10, identifying it as a master regulator governing anthocyanin biosynthesis in pomegranate. Limited availability of stable genetic transformation systems restricts functional genomics research in pomegranate. Here, we established efficient in vitro regeneration and Agrobacterium tumefaciens-mediated transformation systems for 'Taishanhong' pomegranate using stem segment explants. Optimized medium combinations produced high-frequency regeneration: a 93.3% shoot-induction rate on MS medium with 1.5 mg/L 6-benzylaminopurine (BAP), 0.6 mg/L 1-naphthaleneacetic acid (NAA) and 30.0 mg/L adenine sulfate (ADS); a proliferation coefficient of 5.4 on MS medium supplemented with 0.8 mg/L BAP and 0.3 mg/L indole‑3‑butyric acid (IBA); effective shoot-strengthening on MS medium containing 1.2 mg/L BAP, 0.3 mg/L NAA and 0.2 mg/L gibberellic acid (GA₃); and a rooting rate of 95.3% on half-strength MS medium with 1.5 mg/L IBA and 0.5 mg/L NAA. For transformation, precultured explants were immersed with A. tumefaciens suspension (OD₆₀₀ = 0.8) containing 20.0 mg/L acetosyringone (AS) for 30 min. After four days of dark co-culture, sequential antibiotic screening with 30 mg/L kanamycin and bacteriostatic treatment with 400 mg/L timentin yielded a stable average transformation efficiency of 17.5% in 'Taishanhong' pomegranate. Subsequent functional analysis revealed that overexpression of PgMYB10 induced pigment accumulation in leaves and stems. In three independent transgenic lines, maximum anthocyanin content and PgMYB10 transcript levels were 5.4-fold and 27.2-fold higher than in wild-type plants, respectively. Six anthocyanin biosynthetic genes (PgCHS, PgCHI, PgF3H, PgDFR, PgANS, and PgUFGT) were markedly upregulated, demonstrating that PgMYB10 positively controls anthocyanin biosynthesis. This transformation system provides a reliable technical platform for functional genomic studies in pomegranate, and PgMYB10 represents as a promising candidate gene for molecular breeding aimed at improving fruit pigmentation.

Anthocyanins

Natural variation in the PmbHLH162 promoter regulates anthocyanin biosynthesis and accumulation in Prunus mume.

Anthocyanin accumulation is a vital agronomic and ornamental trait, as it not only contributes to adaptation to environmental stress but also enhances ornamental value. In this study, a genome-wide association study (GWAS) was conducted using 328 accessions of mei (Prunus mume) to identify single-nucleotide polymorphisms (SNPs) associated with red pigmentation in petals, filaments, and xylem. Based on these significant SNPs, we defined 2 haplotypes (bHLH162hap1 and bHLH162hap2) and identified PmbHLH162, a bHLH transcription factor gene responsible for anthocyanin biosynthesis regulation. Transient silencing of PmbHLH162 in mei petals via Agrobacterium-mediated transformation resulted in significant color fading, whereas its overexpression dramatically elevated anthocyanin levels. Haplotype analysis showed that 2 promoter variants in bHLH162hap2 (Chr03_2669885 A/C and Chr03_2670272 A/G) alter the binding affinity of transcription factors PmWRKY18 and PmWRKY70. Stronger binding to the G/C alleles gave rise to higher PmbHLH162 expression in bHLH162hap2, thereby promoted red pigmentation in multiple tissues. By contrast, accessions carrying bHLH162hap1 displayed light/colorless phenotype without accumulation of red pigment. Furthermore, PmbHLH162 interacted respectively with PmMYC2, PmTT8, and PmEGL1 to form heterodimers, and markedly enhanced PmMYC2-mediated transcriptional activation of the anthocyanin biosynthetic structural genes PmCHS and PmANS. Geographic haplotype analysis revealed that bHLH162hap2 was predominantly enriched in high-latitude northern populations but was declining markedly at lower latitudes. Collectively, our study reveals the genetic and molecular basis underlying anthocyanin accumulation in mei and identifies a PmbHLH162-PmMYC2 regulatory module in which PmbHLH162 enhances PmMYC2-mediated activation of key anthocyanin biosynthetic genes. The additional interactions of PmbHLH162 with the MBW-associated bHLH factors PmTT8 and PmEGL1 further suggest potential crosstalk between this module and the canonical anthocyanin regulatory network.

Anthocyanins

R2R3-MYB transcription factor MYB113 specifically regulates anthocyanin accumulation in Lycium ruthenicum.

LrMYB113 drives anthocyanin biosynthesis in Lycium ruthenicum by forming an MBW complex and directly activating LrDFR and LrANS promoters, providing a genetic target for enhancing flavonoid production. Lycium ruthenicum Murray (black goji berry), a Solanaceae medicinal plant, is valued for its high flavonoid content. However, the transcriptional regulation of flavonoid biosynthesis in L. ruthenicum remains unclear, hindering its pharmaceutical development. Here, we identified and characterized LrMYB113, an R2R3-MYB transcription factor, as a key regulator of anthocyanin biosynthesis in L. ruthenicum. Phylogenetic analysis grouped LrMYB113 into the anthocyanin-associated S6 subgroup of MYBs. Heterologous expression of LrMYB113 in tobacco induced pigment accumulation and upregulated anthocyanin pathway genes. LrMYB113 overexpression in L. ruthenicum hairy roots enhanced accumulation of four acylated anthocyanins and activated anthocyanin pathway genes. Yeast two-hybrid and bimolecular fluorescence complementation assays showed LrMYB113 interacts with bHLHs (LrJAF13/LrAN1b) and WD40 (LrAN11) to form an MBW complex. Promoter binding and transactivation assays demonstrated LrMYB113 directly binds to and activates LrDFR and LrANS promoters. Dual-luciferase assays showed LrMYB113 alone strongly activates LrDFR and LrANS promoters; MBW complexes enhanced activity compared to individual bHLH/WD40 but not to LrMYB113 alone. Our findings identify LrMYB113 as a critical regulator of anthocyanin biosynthesis in L. ruthenicum, shedding light on flavonoid molecular mechanisms and supporting genetic improvement for pharmaceutical use.

Anthocyanins